313 related articles for article (PubMed ID: 8641192)
21. Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance.
Huan JN; Li J; Han Y; Chen K; Wu N; Zhao AZ
J Biol Chem; 2003 Nov; 278(46):45638-50. PubMed ID: 12925533
[TBL] [Abstract][Full Text] [Related]
22. Effect of central obesity on regulation of carbohydrate metabolism in obese patients with varying degrees of glucose tolerance.
Golay A; Chen N; Chen YD; Hollenbeck C; Reaven GM
J Clin Endocrinol Metab; 1990 Nov; 71(5):1299-304. PubMed ID: 2229287
[TBL] [Abstract][Full Text] [Related]
23. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet.
Cansby E; Amrutkar M; Mannerås Holm L; Nerstedt A; Reyahi A; Stenfeldt E; Borén J; Carlsson P; Smith U; Zierath JR; Mahlapuu M
FASEB J; 2013 Sep; 27(9):3660-71. PubMed ID: 23729594
[TBL] [Abstract][Full Text] [Related]
25. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
[TBL] [Abstract][Full Text] [Related]
26. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.
Brüning JC; Michael MD; Winnay JN; Hayashi T; Hörsch D; Accili D; Goodyear LJ; Kahn CR
Mol Cell; 1998 Nov; 2(5):559-69. PubMed ID: 9844629
[TBL] [Abstract][Full Text] [Related]
27. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle.
Capozza F; Combs TP; Cohen AW; Cho YR; Park SY; Schubert W; Williams TM; Brasaemle DL; Jelicks LA; Scherer PE; Kim JK; Lisanti MP
Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1317-31. PubMed ID: 15689413
[TBL] [Abstract][Full Text] [Related]
28. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.
Fernández AM; Kim JK; Yakar S; Dupont J; Hernandez-Sanchez C; Castle AL; Filmore J; Shulman GI; Le Roith D
Genes Dev; 2001 Aug; 15(15):1926-34. PubMed ID: 11485987
[TBL] [Abstract][Full Text] [Related]
29. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
Evans DJ; Murray R; Kissebah AH
J Clin Invest; 1984 Oct; 74(4):1515-25. PubMed ID: 6148358
[TBL] [Abstract][Full Text] [Related]
30. Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats.
Henriksen EJ; Jacob S; Fogt DL; Youngblood EB; Gödicke J
Hypertension; 1997 Dec; 30(6):1560-5. PubMed ID: 9403583
[TBL] [Abstract][Full Text] [Related]
31. Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats.
Cahová M; Vavrinková H; Tutterova M; Meschisvilli E; Kazdova L
Metabolism; 2003 Nov; 52(11):1406-12. PubMed ID: 14624398
[TBL] [Abstract][Full Text] [Related]
32. Prevention of obesity and insulin resistance by glucokinase expression in skeletal muscle of transgenic mice.
Otaegui PJ; Ferre T; Riu E; Bosch F
FASEB J; 2003 Nov; 17(14):2097-9. PubMed ID: 14500548
[TBL] [Abstract][Full Text] [Related]
33. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
Cariou B; van Harmelen K; Duran-Sandoval D; van Dijk TH; Grefhorst A; Abdelkarim M; Caron S; Torpier G; Fruchart JC; Gonzalez FJ; Kuipers F; Staels B
J Biol Chem; 2006 Apr; 281(16):11039-49. PubMed ID: 16446356
[TBL] [Abstract][Full Text] [Related]
34. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
Norris AW; Chen L; Fisher SJ; Szanto I; Ristow M; Jozsi AC; Hirshman MF; Rosen ED; Goodyear LJ; Gonzalez FJ; Spiegelman BM; Kahn CR
J Clin Invest; 2003 Aug; 112(4):608-18. PubMed ID: 12925701
[TBL] [Abstract][Full Text] [Related]
35. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1.
Jong MC; Voshol PJ; Muurling M; Dahlmans VE; Romijn JA; Pijl H; Havekes LM
Diabetes; 2001 Dec; 50(12):2779-85. PubMed ID: 11723061
[TBL] [Abstract][Full Text] [Related]
36. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.
Castellani LW; Goto AM; Lusis AJ
Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886
[TBL] [Abstract][Full Text] [Related]
37. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance.
Arce-Cerezo A; García M; Rodríguez-Nuevo A; Crosa-Bonell M; Enguix N; Peró A; Muñoz S; Roca C; Ramos D; Franckhauser S; Elias I; Ferre T; Pujol A; Ruberte J; Villena JA; Bosch F; Riu E
Sci Rep; 2015 Sep; 5():14487. PubMed ID: 26411793
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake.
Chang PY; Jensen J; Printz RL; Granner DK; Ivy JL; Moller DE
J Biol Chem; 1996 Jun; 271(25):14834-9. PubMed ID: 8662926
[TBL] [Abstract][Full Text] [Related]
39. Skeletal Muscle Tissue Trib3 Links Obesity with Insulin Resistance by Autophagic Degradation of AKT2.
Kwon M; Eom J; Kim D; Kim J; Heredia J; Kang SW; Song Y
Cell Physiol Biochem; 2018; 48(4):1543-1555. PubMed ID: 30071535
[TBL] [Abstract][Full Text] [Related]
40. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.
Weiss R; Dufour S; Taksali SE; Tamborlane WV; Petersen KF; Bonadonna RC; Boselli L; Barbetta G; Allen K; Rife F; Savoye M; Dziura J; Sherwin R; Shulman GI; Caprio S
Lancet; 2003 Sep; 362(9388):951-7. PubMed ID: 14511928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
